Healthcare experts urge India to rewrite clinical trial rules to boost global market share

Healthcare experts suggest that India could increase its share in the global clinical trials market by learning from countries like China and Australia. India currently holds an 8% share, compared to China’s 29%. Experts emphasize improving regulatory speed, offering incentives, and raising patient awareness for trials. India’s clinical trials market is growing, with projected revenues exceeding $2 billion by 2030.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yZKWa2H
via IFTTT